We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
314 hedge funds and large institutions have $3.6B invested in State Street SPDR S&P Biotech ETF in 2017 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 116 increasing their positions, 76 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
76% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 34
53% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 76
25% more funds holding in top 10
Funds holding in top 10: 12 → 15 (+3)
17% more capital invested
Capital invested by funds: $3.09B → $3.6B (+$511M)
8% more funds holding
Funds holding: 292 → 314 (+22)
1.67% less ownership
Funds ownership: 97.98% → 96.31% (-1.7%)
42% less call options, than puts
Call options by funds: $826M | Put options by funds: $1.43B
Holders
314
Holders Change
+22
Holders Change %
+7.53%
% of All Funds
7.83%
Holding in Top 10
15
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+25%
% of All Funds
0.37%
New
60
Increased
116
Reduced
76
Closed
34
Calls
$826M
Puts
$1.43B
Net Calls
-$602M
Net Calls Change
-$72.1M
Top Buyers
| 1 |
Citigroup
New York
|
+$135M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$113M |
| 3 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
+$89.1M |
| 4 |
Morgan Stanley
New York
|
+$62.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$52M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$140M |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$105M |
| 3 |
AssetMark Inc
Concord,
California
|
-$42.6M |
| 4 |
JP Morgan Chase
New York
|
-$24.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$23.2M |
